MFDS — authorised 26 May 1953
- Marketing authorisation holder: SANOFI AVENTIS US
- Status: likely_approved
🇰🇷 Thyrogen in South Korea
MFDS authorised Thyrogen on 26 May 1953
Marketing authorisation
Thyrogen in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Thyrogen approved in South Korea?
Yes. MFDS authorised it on 26 May 1953.
Who is the marketing authorisation holder for Thyrogen in South Korea?
SANOFI AVENTIS US holds the South Korean marketing authorisation.